Dr. Noor Abuhadra discusses managing adverse events in patients receiving TRODELVY (sacituzumab govitecan), a later-line systemic therapy for metastatic triple-negative breast cancer. Shay Elkins, a patient, shares her experience with significant side effects including diarrhea, low white blood cell counts, and hair loss, while Dr. Abuhadra emphasizes the need for proactive management of these issues to maximize treatment time and maintain quality of life.
Reginald Tucker-Seeley, MA, ScM, ScD, concludes the program with advice for caregivers and patients with prostate cancer to maximize the benefit of treatment.
Alicia Morgans, MD, MPH, offers advice to patients newly diagnosed with prostate cancer and reviews educational resources available for patients and their caregivers.
Practical advice for improving clinical trials to ensure they are more reflective of the overall population of patients with prostate cancer.
Shay Elkins, a patient with metastatic triple-negative breast cancer, discussed her experience with second-line treatment. Dr. Noor provided insights into the positive outcomes from the ASCENT study.
Rashid K. Sayyid, MD, MSc, discusses the role of combination therapy in metastatic castrate-resistant prostate cancer.
In this on-demand webinar series, CURE partnered with Look Good Feel Better to demonstrate makeup techniques in applying foundation and blush to combat appearance-related side effect from cancer treatment.
In this on-demand webinar series, CURE partnered with Look Good Feel Better to discuss skincare during cancer treatment to assist patients in their daily routine.
In this on-demand webinar series, CURE partnered with Look Good Feel Better to discuss eyebrow shaping techniques and applying eye shadow and mascara to address appearance-related effect from cancer treatment.
In this on-demand webinar series, CURE partnered with Look Good Feel Better to discuss lip care as part of one’s makeup routine to address appearance-related effects from cancer.
Expert oncologists offer closing thoughts on emerging therapeutic strategies, unmet needs, and the future of kidney cancer treatment.
Chandler H. Park, MD, discusses the role of support groups and outlines resources available to patients with kidney cancer.
One expert explains why palliative care for patients with cancer “is about aligning the patient's goals and the family's goals with the therapeutic goals.”
Rashid K. Sayyid, MD, MSc, gives a brief overview of treatment options for nonmetastatic castrate-resistant prostate cancer.
Expert perspectives on the treatment approach for patients with metastatic castrate-resistant prostate cancer.
An expert on prostate cancer gives a brief overview of castrate-resistant prostate cancer.
“When people see me, they just feel like they have to start jogging,” as one chief nurse practitioner tells CURE when discussing how patients with MPNs can reduce their risk of cardiovascular and thrombotic events.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to discuss ways patients can be empowered to receive the best care possible.
this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to negate common clinical trial misperceptions.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to discuss how women of color with breast cancer can learn more about their disease.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to discuss low clinical trial participation in Black patients with breast cancer, and factors that may be contributing.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to discuss racial disparities in breast cancer.
Tian Zhang, MD, MHS, provides an overview of the treatment of patients with non–clear cell renal cell carcinoma.
An overview of the treatment protocol for patients with advanced RCC who are receiving IO/TKI or IO/IO combination therapy.
Shay Elkins, a patient with triple negative breast cancer, shares her experience of relapse six months post-treatment, eventually leading her to seek a second opinion for her recurring symptoms. Dr. Noor Abuhadra discusses second-line treatment options for metastatic triple negative breast cancer, emphasizing newer therapies like antibody drug conjugates and PARP inhibitors, and highlights the evolving landscape that offers hope for patients.
Dr Noor Abuhadra discusses the various first-line treatment options for metastatic TNBC, highlighting the importance of PDL1 expression for immunotherapy and germline testing for targeted therapies like PARP inhibitors. Patient Shay Elkins shares her treatment journey, from her initial chemo and immunotherapy to surgical intervention, emphasizing the importance of a collaborative approach with her healthcare team and the supportive role of nursing staff.
A childhood cancer specialist discusses how oncology drug shortages may affect the treatment of children with cancer.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to offer resources for women of color with breast cancer that can help with emotional support throughout their journey.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to share ways patients can delegate tasks in order to take care of themselves during their cancer journey.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to offer advice and ways patients can seek support to ensure they are taking care of their mental and emotional health after a breast cancer diagnosis.
